僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Emapalumab （NI-0501） is a humanized monoclonal IgG1 antibody that noncompetitively inhibits IFN-γ. Emapalumab binds with high affinity （Kd= 1.4 pM） to both free IFN-γ as well as IFN-γ bound to its receptor. Emapalumab can be used in research of hemophagocytic lymphohistiocytosis （HLH）